Tag - covid-19-vaccines

 
 

COVID 19 VACCINES

Japan Times
WORLD
Dec 21, 2021
WHO sounds warning over fast-spreading omicron
WHO chief scientist Soumya Swaminathan said it would be 'unwise' to conclude from early evidence that omicron was a milder variant than previous ones.
Japan Times
WORLD
Dec 21, 2021
EU backs Novavax shot as region's fifth COVID-19 vaccine
It is not clear yet how Novavax performs against the omicron variant, or whether a booster dose will be needed.
Japan Times
JAPAN / Explainer
Dec 20, 2021
Japan has released its digital vaccine passport. Here's what you need to know.
The digital version of the proof of vaccination issued by municipalities is joined by a new online service intended to simplify entry procedures for travelers.
Japan Times
WORLD / Science & Health
Dec 20, 2021
Moderna says its booster dose appears protective against omicron
The data, which has not yet been peer reviewed, tested blood from people who had received the vaccine against a pseudovirus engineered to resemble the omicron variant.
Japan Times
WORLD
Dec 20, 2021
Most of the world’s vaccines likely won’t prevent infection from omicron
They do seem to offer significant protection against severe illness, but the consequences of rapidly spreading infection worry many public health experts.
Japan Times
JAPAN
Dec 18, 2021
Japan to shorten booster shot interval for medical workers and seniors on omicron concerns
The interval between second shots and booster shots will be six months for health care workers and those living in nursing homes, the prime minister said.
Japan Times
WORLD / FOCUS
Dec 18, 2021
Omicron rewrites the COVID plan for 2022
As the omicron variant gains momentum in Europe and the United States, scientists are rewriting their expectations for the COVID-19 pandemic next year.
Japan Times
WORLD / Science & Health
Dec 18, 2021
Pfizer says pandemic could extend through 2023, studies three-dose vaccine course for children
Pfizer executives said the company believed that by 2024, the disease should be endemic around the globe, meaning it would no longer be a pandemic.
Japan Times
BUSINESS
Dec 17, 2021
Pfizer will dominate $20 billion COVID-19 pill market in 2022, analysis shows
Demand for the medications is poised to outpace supply as COVID-19 spreads around the globe and scientists question how well vaccines and antibody treatments will hold up against omicron.
Japan Times
WORLD
Dec 16, 2021
Refugees lack COVID-19 shots because drugmakers fear lawsuits
Legal concerns add new hurdles to fighting the virus since unvaccinated people offer an ideal environment for it to mutate and threaten hard-won immunity around the world.
Japan Times
WORLD
Dec 16, 2021
New studies raise hopes that vaccines prevent severe omicron cases
Scientists reported on several studies suggesting that T cells in vaccinated people can put up a strong defense against the variant.
Japan Times
JAPAN / Science & Health
Dec 15, 2021
Health ministry formally approves Moderna’s COVID-19 vaccine for a booster shot
The government plans to allow booster shots six months after the second shot whenever possible — a reduced timeline from the current plan of eight months.
Japan Times
WORLD
Dec 15, 2021
Conservatives abandon Boris Johnson over new COVID-19 rules
With nearly 100 lawmakers from Johnson's own party voting against him, it was a stinging rebuke of their leader that undermines his authority just as omicron threatens the country.
Japan Times
BUSINESS
Dec 14, 2021
Moderna to produce millions of mRNA vaccines in Australia
The deal underscores efforts by governments around the world to build up local production and prepare for future pandemic threats.
Japan Times
WORLD
Dec 14, 2021
Vaccine mandates rekindle fierce debate over civil liberties
Across Europe's democracies, the latest wave of the pandemic is prompting governments to reimpose sweeping restrictions on free movement and mixing in their societies.
Japan Times
WORLD
Dec 13, 2021
Britain says omicron accounts for 40% of London infections
Britain said on Monday that the omicron variant of coronavirus was spreading at a "phenomenal rate" and accounted for about 40% of all infections in London so people should get an additional dose of the vaccine because double-jabbed people are vulnerable.
Japan Times
BUSINESS
Dec 13, 2021
Billionaire’s bet on Pfizer vaccine for China fails to pay off
Xi Jinping's administration has backed a nationalist agenda on all fronts, including in the fight against the virus.
Japan Times
JAPAN
Dec 11, 2021
Japan's low COVID-19 death rate may be due to genetics, top research institute says
Most Japanese have an inherited component of the immune system that can more effectively kill various coronaviruses, including the one that causes COVID-19, scientists say.
Japan Times
WORLD / Science & Health / FOCUS
Dec 11, 2021
Two weeks into the omicron outbreak: Where to from here?
A little more than two weeks since omicron's discovery a lot has been learned about the latest coronavirus variant. A lot remains to be discovered.
Japan Times
WORLD / Science & Health
Dec 11, 2021
Boosters provide 70% to 75% omicron protection in U.K. study
The findings come as the U.K. accelerates its booster campaign in the face of the heavily mutated variant.

Longform

Sociologist Gracia Liu-Farrer argues that even though immigration doesn't figure into Japan's autobiography, it is more of a self-perception than a reality.
In search of the ‘Japanese dream’